Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $4.37 and traded as low as $4.20. Galmed Pharmaceuticals shares last traded at $4.54, with a volume of 121,399 shares.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Galmed Pharmaceuticals in a research report on Wednesday, October 9th. They issued a “sell” rating for the company.

Galmed Pharmaceuticals Stock Down 5.6 %

The company has a 50 day moving average of $4.79 and a two-hundred day moving average of $4.37. The firm has a market cap of $22.90 million, a P/E ratio of -1.89 and a beta of 0.73.

Galmed Pharmaceuticals (NASDAQ:GLMD) last posted its quarterly earnings data on Wednesday, August 28th. The biopharmaceutical company reported $2.16 earnings per share for the quarter.

Galmed Pharmaceuticals Company Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.